The Technion’s story has been intertwined with Israel’s for more than a century, from laying the foundations for a new nation to shaping its future.
Step inside Israeli innovation at the David and Janet Polak Visitors Center. Experience our 360° immersive movie and tech exhibition. Open to individuals and groups.
Learn More
There is no guarantee for preventing stroke, but eating healthy, exercising, and regular medical check-ups go a long way. Now it seems we can reduce stroke risks even more with computer science. Two Technion master’s degree students have written a machine learning algorithm that can accurately predict whether a person will develop the irregular heart rhythm atrial fibrillation (AFib) — a condition that causes one in seven strokes. Working under the supervision of Assistant Professor Joachim A. Behar, head of the Artificial Intelligence Laboratory in Medicine, Shany Biton and Sheina Gendelman accessed more than one million ECG recordings from more…
Guiding a medical needle through the body to do biopsies and other treatment is not an easy task. Straight needles work when the path is a straight shot, but often the target is hidden behind bones or vulnerable tissue. In recent years scientists have developed medical needles with beveled tips and algorithms to direct the needles, but the procedure is still risky. Now a team from the Technion and the University of North Carolina have developed a new algorithm that hopes to make the task safer and more precise.
Due to the scarcity of organ donors, many of the nearly 92,000 Americans awaiting kidney donations will not survive the transplant wait list. Now, a collaborative partnership to produce 3D printed kidneys is aimed at reducing wait times in the U.S. and around the world. Israeli-based CollPlant Biotechnologies, led by Technion alum Yechiel Tal ’79, M.S.’82, is working with United Therapeutics Corporation to manufacture artificial kidneys by combining CollPlant’s unique tobacco-based platform with its BioInk technology. In preparation for entering production, the companies have, ironically, turned a former tobacco plant into a modern 3D bioprinting factory. “We are excited to…
Scientists from the Technion have found a way to rejuvenate the aging process of the body’s immune system. Professor Doron Melamed, principal investigator in the Richard and Kenneth Skodnek Developmental Immunology and Aging Research Laboratory, and doctoral student Reem Dowery sought to understand why the elderly population is more susceptible to severe cases of COVID-19 and why the vaccines seem to be less effective and wane faster among this population. The results of their work were published recently in the peer-reviewed, online medical journal Blood. The secret begins with B cells, also known as B lymphocytes, which protect us from…
The Israeli company Bonus BioGroup, co-founded by Technion alumnus Shai Meretzki, has been given the green light to expand use of its innovative COVID treatment after severely ill patients showed dramatic results earlier this year. Dr. Meretzki earned dual bachelor’s degrees from the Technion in 1996 in both chemical engineering and biology, and his master’s and Ph.D. degrees — also from the Technion — in biotechnology in 1999 and 2002, respectively. Just one day after taking their last dose of Bonus Biogroup’s MesenCure, 10 patients were well enough to be released from Israel’s Rambam Hospital. Chest x-rays showed a drop…
Technion scientists have produced a highly stretchable electronic material and a wearable sensor capable of precisely identifying bending and twisting motion. Together, they form an electronic “skin” capable of recognizing the range of movement human joints normally make, with up to half a degree precision. This breakthrough is the result of collaborative work between researchers from the Laboratory for Nanomaterial-Based Devices, headed by Professor Hossam Haick from the Wolfson Faculty of Chemical Engineering. The results were recently published in Advanced Materials and featured on the journal’s cover.
Featuring Cincinnati Children’s Hospital Medical Center’s Professor Marc Rothenberg and Technion Professors Yonatan Savir and Shai Shen-Orr Two world-class institutions joined powers to unlock the potential of big data to transform child health. Relive this special launch event to celebrate a research partnership between Technion and Cincinnati Children’s Hospital Medical Center that aims to revolutionize pediatric medicine for decades to come. The alliance established an innovative, data-driven program that could lead to the discovery of new treatments, help clinicians improve personalized medicine, and deliver the best possible health care to children around the globe. Meet some of the esteemed scientists…
Pictured above: Professor Reem Dowery (left) and Professor Doron Melamed Since the start of the COVID-19 pandemic, the scientific community has been bewildered by a mystery: why does the elderly population appear to be more vulnerable to COVID-19, and why are vaccines less effective in protecting them? Technion doctoral student Reem Dowery may have discovered the reason why. Memory B lymphocytes are cells within the human body that are responsible for long-term production of effective antibodies. They are formed when the body is exposed to a new pathogen, such as a virus. Upon consequent exposures to the same pathogen, they…
Meteoric progress has been made in the world of deep learning and artificial intelligence. Yet there are virtually no medical products on the market that tap into AI’s life-changing potential. Until now. Professor Yael Yaniv of the Faculty of Biomedical Engineering joined forces with the research groups of Professors Alex Bronstein and Assaf Schuster of the Henry and Marilyn Taub Faculty of Computer Science to develop an AI-based system that analyzes electrocardiograms (ECGs) and automatically detects heart disease. The electrocardiogram, developed more than a century ago, provides important information on conditions affecting the heart. It is a quick and non-invasive…
As one of the few engineering institutes worldwide with its own medical school, the Technion has transformed our knowledge of human health. Its scientists have made great strides in cancer research, personalized medicine, targeted drug delivery, and COVID-19 testing. Here are just two recent medical breakthroughs.
Pictured above: Graphic rendition on skin adhesive sensors for tuberculosis from Technion Israel Detection There is a vaccination that prevents it, and drugs that can kill it. Yet tuberculosis, colloquially known as consumption, is still prevalent and deadly. In 2019, tuberculosis infected an estimated 10 million people globally, killing 1.4 million — 95% of cases occurring in the developing world. One reason TB is still with us is delayed diagnosis. Early symptoms are non-specific, and existing TB testing is slow and often too complex and expensive for facilities with limited resources. Therefore, some 3 million cases are missed each year,…